FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells.


Journal

Neoplasma
ISSN: 0028-2685
Titre abrégé: Neoplasma
Pays: Slovakia
ID NLM: 0377266

Informations de publication

Date de publication:
28 Nov 2023
Historique:
received: 04 01 2023
accepted: 13 11 2023
medline: 28 11 2023
pubmed: 28 11 2023
entrez: 28 11 2023
Statut: aheadofprint

Résumé

F-box and WD repeat domain containing 7 (FBXW7) is an aboriginal and high-frequency mutant gene associated with esophageal squamous cell carcinoma (ESCC). This study was designed to determine the clinical value and molecular mechanisms of FBXW7 in the development of ESCC. The clinical significance of FBXW7 was analyzed in ESCC from TCGA data. The effects of FBXW7 on proliferation, colony formation, migration and invasion, angiogenesis, and apoptosis were tested in ESCC cells. PCR-array, sphere formation assay, and quantitative real-time polymerase chain reaction (qPCR) were used to explore the mechanism of FBXW7. FBXW7 was a significantly mutated gene in ESCC. It was an independent and potential predictor for survival in ESCC patients. In addition, FBXW7 overexpression significantly inhibited ESCC cell proliferation, migration, invasion, angiogenesis, and promoted cell apoptosis. PCR array revealed that FBXW7 overexpression leads to a significant change of genes expression associated with angiogenesis, cell senescence, and DNA damage and repair. Sphere formation assay and qPCR showed FBXW7 was associated with ESCC stem cell formation. Our results suggest that FBXW7 may act as a tumor suppressor by repressing cancer stem cell formation and regulating tumor angiogenesis, cell senescence, DNA damage, and repair in ESCC.

Identifiants

pubmed: 38014700
doi: 10.4149/neo_2023_230104N8
pii: 230104N8
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yanghui Bi (Y)

General Surgery Department of Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi, China.

Yanfang Yang (Y)

Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.

Yong Zhang (Y)

Endoscopic Center of Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.

Caixia Cheng (C)

Department of Pathology, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi, China.

Peisen Tang (P)

Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, China.

Heng Xiao (H)

Department of Pathology and Shanxi Key Laboratory of Carcinogenesis and Translational Research of Esophageal Cancer, Shanxi Medical University, Taiyuan, Shanxi, China.

Fajia Yuan (F)

Shanxi Province Jinzhong City Health School, Jinzhong, Shanxi, China.

Weiwei Wu (W)

Department of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.

Bin Yang (B)

3rd Department of Thoracic Surgery Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.

Classifications MeSH